• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Barriers to adequate delivery of hemodialysis.

作者信息

Sehgal A R, Snow R J, Singer M E, Amini S B, DeOreo P B, Silver M R, Cebul R D

机构信息

Division of Nephrology, MetroHealth Medical Center, Cleveland, OH 44109-1998, USA.

出版信息

Am J Kidney Dis. 1998 Apr;31(4):593-601. doi: 10.1053/ajkd.1998.v31.pm9531174.

DOI:10.1053/ajkd.1998.v31.pm9531174
PMID:9531174
Abstract

Mortality rates among American hemodialysis patients are the highest in the industrialized world. Measures of delivered dialysis (Kt/V) correspond strongly with survival and are estimated to be inadequate in one third of patients. We sought to determine the importance of potential barriers to adequate dialysis, including patient-related and technical factors. Using a cross-sectional study design, we abstracted the charts of 721 randomly selected patients from all 22 chronic hemodialysis units in northeast Ohio. For each of 1,836 treatments provided to these patients, we assessed delivered dialysis (Kt/V) and patient-related factors (ie, hypotension, intradialytic symptoms, and treatment time missed due to noncompliance or transportation problems) and technical factors (ie, dialysis prescription, type of vascular access, clotting, and dialyzer reuse). We used hierarchical regression analysis to determine which potential barriers were independently related to delivered dialysis after adjustment for patient demographic and medical characteristics. Barriers independently related to dialysis delivery (all P values < 0.001) included patient noncompliance, present in 3% of treatments; low dialysis prescription, 14%; use of a catheter for vascular access, 11%; and clotting, 1%. The prevalence of identified barriers varied dramatically across facilities (eg, the prevalence of low dialysis prescription ranged from 0% to 37%, while the prevalence of catheter use ranged from 3% to 28%). In conclusion, patient noncompliance, low dialysis prescription, catheter use, and clotting are the most important barriers to dialysis delivery. Further work is needed to develop interventions to overcome these barriers and to determine the effect of such interventions on dialysis adequacy and patient survival.

摘要

相似文献

1
Barriers to adequate delivery of hemodialysis.
Am J Kidney Dis. 1998 Apr;31(4):593-601. doi: 10.1053/ajkd.1998.v31.pm9531174.
2
Identifying patients at risk for hemodialysis underprescription.识别有血液透析处方不足风险的患者。
Am J Nephrol. 2001 May-Jun;21(3):200-7. doi: 10.1159/000046248.
3
Improving the quality of hemodialysis treatment: a community-based randomized controlled trial to overcome patient-specific barriers.提高血液透析治疗质量:一项基于社区的随机对照试验,以克服患者个体障碍。
JAMA. 2002 Apr 17;287(15):1961-7. doi: 10.1001/jama.287.15.1961.
4
Barriers to adequate protein nutrition among hemodialysis patients.血液透析患者充足蛋白质营养的障碍
J Ren Nutr. 1998 Oct;8(4):179-87. doi: 10.1016/s1051-2276(98)90016-4.
5
Barriers to the delivery of adequate hemodialysis in ESRD Network 4.终末期肾病网络4中充分进行血液透析的障碍。
Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S11-20.
6
Morbidity and cost implications of inadequate hemodialysis.血液透析不充分的发病率及成本影响
Am J Kidney Dis. 2001 Jun;37(6):1223-31. doi: 10.1053/ajkd.2001.24526.
7
Improving adequacy of hemodialysis in Northern California ESRD patients: a final project report. Provider Participants and Medical Review Board of the TransPacific Renal Network.提高北加利福尼亚终末期肾病患者的血液透析充分性:最终项目报告。泛太平洋肾脏网络的提供者参与者和医学审查委员会。
Adv Ren Replace Ther. 2000 Oct;7(4 Suppl 1):S85-94.
8
Why are hemodialysis treatments shortened and skipped? Development of a taxonomy and relationship to patient subgroups.为什么血液透析治疗会被缩短和跳过?分类法的发展及其与患者亚组的关系。
Nephrol Nurs J. 2003 Apr;30(2):209-17; discussion 218.
9
[REIN Report 2011--summary].[2011年肾脏疾病改善全球结果(KDIGO)报告——摘要]
Nephrol Ther. 2013 Sep;9 Suppl 1:S3-6. doi: 10.1016/S1769-7255(13)70036-1.
10
[The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].[威尼托地区透析与移植登记处:2006 - 2007年报告]
G Ital Nefrol. 2009 Nov-Dec;26 Suppl 48:S5-56.

引用本文的文献

1
The impact of dialysate flow rate on haemodialysis adequacy: a systematic review and meta-analysis.透析液流速对血液透析充分性的影响:一项系统评价和荟萃分析。
Clin Kidney J. 2024 Jun 4;17(7):sfae163. doi: 10.1093/ckj/sfae163. eCollection 2024 Jul.
2
The prognostic value of URR equals that of Kt/V for all-cause mortality in Taiwan after 10-year follow-up.URR 在台湾地区全因死亡率方面的预后价值与 Kt/V 相当,随访 10 年后得出该结果。
Sci Rep. 2023 Jun 1;13(1):8923. doi: 10.1038/s41598-023-35353-8.
3
Ultrasonographic evaluation of deep vein thrombosis related to the central catheter in hemodialytic patients.
血液透析患者中心静脉导管相关深静脉血栓形成的超声评估
Ultrasound J. 2022 Jan 10;14(1):4. doi: 10.1186/s13089-021-00252-4.
4
Central Venous Catheters for Hemodialysis-the Myth and the Evidence.用于血液透析的中心静脉导管——神话与证据
Kidney Int Rep. 2021 Oct 11;6(12):2958-2968. doi: 10.1016/j.ekir.2021.09.009. eCollection 2021 Dec.
5
Ensuring hemodialysis adequacy by dialysis dose monitoring with UV spectroscopy analysis of spent dialyzate.通过对废弃透析液进行紫外线光谱分析的透析剂量监测来确保血液透析充分性。
Int J Artif Organs. 2022 Apr;45(4):351-359. doi: 10.1177/03913988211059841. Epub 2021 Nov 23.
6
Assessment of hemodialysis adequacy and its relationship with individual and personal factors.血液透析充分性评估及其与个体和个人因素的关系。
Iran J Nurs Midwifery Res. 2016 Nov-Dec;21(6):577-582. doi: 10.4103/1735-9066.197673.
7
Clinical usefulness of kidney biopsy in liver transplant recipients with renal impairment.肝移植受者肾功能损害时行肾活检的临床价值。
Kidney Res Clin Pract. 2013 Dec;32(4):153-7. doi: 10.1016/j.krcp.2013.08.002. Epub 2013 Oct 24.
8
Predicting Early Death Among Elderly Dialysis Patients: Development and Validation of a Risk Score to Assist Shared Decision Making for Dialysis Initiation.预测老年透析患者的早期死亡:用于辅助透析起始共同决策的风险评分的开发与验证
Am J Kidney Dis. 2015 Dec;66(6):1024-32. doi: 10.1053/j.ajkd.2015.05.014. Epub 2015 Jun 26.
9
Tailored interventions to address determinants of practice.针对实践决定因素的量身定制干预措施。
Cochrane Database Syst Rev. 2015 Apr 29;2015(4):CD005470. doi: 10.1002/14651858.CD005470.pub3.
10
Combined functional and anatomical diagnostic endpoints for assessing arteriovenous fistula dysfunction.用于评估动静脉内瘘功能障碍的联合功能和解剖学诊断终点
World J Nephrol. 2015 Feb 6;4(1):6-18. doi: 10.5527/wjn.v4.i1.6.